CUBT
Curative Biotechnology, Inc.
Set alert
- YTD
- +2.40%
- 1 year
- -21.01%
- Open
- 0.69
- Prev close
- 0.8299
- Mkt cap
- 7.38M
- Vol
- 717
- Avg vol
- 915
- EPS
- -0.44
- P/E
- 0.00
More statistics
- Low
- 0.69
- High
- 0.8294
News
1 month ago globenewswire.com
Curative Biotechnology, Inc. Issues Letter to Shareholders
Company Reviews Significant Ophthalmology, Intellectual Property and Translational Development Milestones Achieved Over the Past Year Palm Beach Gardens, FL, Sept. 11, 2026 (GLOBE NEWSWIRE) --…
5 months ago globenewswire.com
Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement
PennVet Study to Evaluate GMP-Grade Metformin Eye Drops in a Canine Model Supporting Human and Veterinary Development Pathways Palm Beach Gardens, FL, May 07, 2026 (GLOBE NEWSWIRE) -- Curative…
7 months ago globenewswire.com
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting
Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBTD) (“Curative” or the…
7 months ago globenewswire.com
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting
Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative" or the…
9 months ago globenewswire.com
Curative Biotechnology Announces Canadian Patent Allowance
“Druggable Target to Treat Retinal Degeneration” Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the “Company”), a company developing…
11 months ago globenewswire.com
Curative Biotechnology, Inc. Announces Letter to Shareholders
Strategic Update and New Path to Value Creation Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a…
1 year ago globenewswire.com
Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor
Palm Beach Gardens, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel…
2 years ago headlinesoftoday.com
Curative Biotechnology, Inc. Announces Nomination of Dr.
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company…
2 years ago globenewswire.com
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Palm Beach Gardens, FL, and Tokyo, Japan, March 31, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company…
2 years ago headlinesoftoday.com
Curative Biotechnology, Inc. Announces Nomination of Dr.
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel…
2 years ago globenewswire.com
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel…
2 years ago globenewswire.com
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange
3 years ago globenewswire.com
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange
5 years ago globenewswire.com
CURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO
Dr. Sohn to Oversee Development of Next Gen COVID-19 Vaccine to Treat Kidney Failure Patients , Late-Stage Rabies Therapeutic and Age-related Macular Degeneration
5 years ago globenewswire.com
CURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINE
License from Mid-Atlantic BioTherapeutics for IMT504 Broadens Scope of Initial License Beyond Treatment of Symptomatic Rabies
5 years ago prnewswire.com
Curative Biotechnology Announces IMT504 License For Development Of Proprietary Next-Gen COVID-19 Vaccine
BOCA RATON, Fla., Oct. 7, 2021 /PRNewswire/ -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative Biotech" or the "Company") announced today that the Company has reached agreement with Mid-Atlantic…
5 years ago globenewswire.com
Curative Biotechnology, Inc. Announces Addition of Dr. Nicholas Boulis to Scientific and Clinical Advisory Board
Company's Clinical Program for CD56 Monoclonal Antibody Drug Conjugate for Treatment of Glioblastoma to Benefit from Exper tise in Neurobiology